About us
Yue Shen, PhD
Senior Vice President of Medicine
B.S. in Biology & B.S. in Economics, Peking University;
Ph.D.in Biology, California Institute of Technology & M.S. in Regulatory Sciences, University of Southern California; Affiliate Professor, Jinan University
15 years’ experience in R&D and Regulatory affairs. Served as Manager of Global Regulatory Affairs at Novartis Vaccines & Diagnostics, received 20+ IVD and medical device approvals in APAC and North America;
Managed Global Regulatory Affairs at Betta Pharmaceuticals and then established Betta’s Early Clinical Development Team. Led 10+ first in human studies and clinical pharmacology studies, of which ensartinib (ALKi) has been approved in China since 2020;
Currently leading China clinical development team to conduct clinical development of LP-108, LP-118, LP-168, etc.